Bicycle Therapeutics (BCYC) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free BCYC Stock Alerts $21.36 -0.82 (-3.70%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Bicycle Therapeutics Short Interest DataCurrent Short Volume2,790,000 sharesPrevious Short Volume2,960,000 sharesChange Vs. Previous Month-5.74%Dollar Volume Sold Short$65.43 millionShort Interest Ratio / Days to Cover7.0Last Record DateApril 30, 2024Outstanding Shares42,780,000 sharesPercentage of Shares Shorted6.52%Today's Trading Volume124,459 sharesAverage Trading Volume286,654 sharesToday's Volume Vs. Average43% Short Selling Bicycle Therapeutics ? Sign up to receive the latest short interest report for Bicycle Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBCYC Short Interest Over TimeBCYC Days to Cover Over TimeBCYC Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Bicycle Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,790,000 shares $65.43 million -5.7%N/A7 $23.45 4/15/20242,960,000 shares $64.59 million +16.5%N/A7.4 $21.82 3/31/20242,540,000 shares $63.25 million -0.8%N/A6.6 $24.90 3/15/20242,560,000 shares $60.83 million -7.3%N/A7.1 $23.76 2/29/20242,760,000 shares $69.25 million -18.6%N/A6.1 $25.09 2/15/20243,390,000 shares $74.89 million -10.3%N/A7.2 $22.09 Get the Latest News and Ratings for BCYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,780,000 shares $65.96 million -1.8%N/A7.9 $17.45 1/15/20243,850,000 shares $71.03 million -0.5%N/A7.1 $18.45 12/31/20233,870,000 shares $69.97 million -4.2%N/A7 $18.08 12/15/20234,040,000 shares $70.74 million -2.7%N/A7.3 $17.51 11/30/20234,150,000 shares $59.76 million +3.8%N/A8.5 $14.40 11/15/20234,000,000 shares $61.56 million -8.5%N/A9.2 $15.39 10/31/20234,370,000 shares $65.77 million -1.4%N/A10.8 $15.05 10/15/20234,430,000 shares $89.57 million -7.3%N/A12.7 $20.22 9/30/20234,780,000 shares $96.03 million +5.5%N/A14.1 $20.09 9/15/20234,530,000 shares $94.41 million +3.7%N/A14.4 $20.84 8/31/20234,370,000 shares $95.00 million +7.6%N/A16.7 $21.74 8/15/20234,060,000 shares $88.35 million +8.6%N/A17 $21.76 7/31/20233,740,000 shares $92.00 million -13.2%N/A16.7 $24.60 7/15/20234,310,000 shares $112.97 million +1.7%N/A21.7 $26.21 6/30/20234,240,000 shares $108.20 million +1.7%N/A23.8 $25.52 6/15/20234,170,000 shares $110.96 million -0.7%N/A17.9 $26.61 5/31/20234,200,000 shares $100.72 million -0.9%N/A15.5 $23.98 5/15/20234,240,000 shares $101.21 million +15.2%N/A14.7 $23.87 4/30/20233,680,000 shares $72.72 million +5.1%N/A10.8 $19.76 4/15/20233,500,000 shares $66.33 million +0.3%N/A10 $18.95 3/31/20233,490,000 shares $74.23 million +14.4%N/A10 $21.27 3/15/20233,050,000 shares $65.54 million -2.9%N/A10.3 $21.49 2/28/20233,140,000 shares $71.37 million +53.9%N/A10.8 $22.73 2/15/20232,040,000 shares $50.29 million +8.5%N/A7.2 $24.65 1/31/20231,880,000 shares $51.93 million +0.5%N/A7.6 $27.62 1/15/20231,870,000 shares $52.04 million -5.6%N/A8.2 $27.83 12/30/20221,980,000 shares $58.61 million -10.4%N/A8.5 $29.60 12/15/20222,210,000 shares $69.11 million -14.3%N/A9.6 $31.27 11/30/20222,580,000 shares $74.72 million +1.2%N/A10.9 $28.96 11/15/20222,550,000 shares $72.01 million -8.6%N/A11.7 $28.24 10/31/20222,790,000 shares $69.05 million -14.9%N/A12.8 $24.75 10/15/20223,280,000 shares $71.80 million +7.2%N/A15 $21.89 9/30/20223,060,000 shares $71.18 million +5.2%N/A13.9 $23.26 9/15/20222,910,000 shares $71.53 million +1.4%N/A11 $24.58[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. BCYC Short Interest - Frequently Asked Questions What is Bicycle Therapeutics' current short interest? Short interest is the volume of Bicycle Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,790,000 shares of BCYC short. Learn More on Bicycle Therapeutics' current short interest. What is a good short interest ratio for Bicycle Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCYC shares currently have a short interest ratio of 7.0. Learn More on Bicycle Therapeutics's short interest ratio. Which institutional investors are shorting Bicycle Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bicycle Therapeutics: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Bicycle Therapeutics' short interest increasing or decreasing? Bicycle Therapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 2,790,000 shares, a decrease of 5.7% from the previous total of 2,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bicycle Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Bicycle Therapeutics: Tyra Biosciences, Inc. (11.01%), Arcutis Biotherapeutics, Inc. (18.74%), Ocular Therapeutix, Inc. (13.61%), Liquidia Co. (10.62%), Cassava Sciences, Inc. (28.91%), Innoviva, Inc. (18.39%), Centessa Pharmaceuticals plc (2.99%), OPKO Health, Inc. (26.42%), 89bio, Inc. (10.93%), Ironwood Pharmaceuticals, Inc. (13.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Bicycle Therapeutics stock? Short selling BCYC is an investing strategy that aims to generate trading profit from Bicycle Therapeutics as its price is falling. BCYC shares are trading down $0.82 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bicycle Therapeutics? A short squeeze for Bicycle Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCYC, which in turn drives the price of the stock up even further. How often is Bicycle Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCYC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: TYRA Short Interest ARQT Short Interest OCUL Short Interest LQDA Short Interest SAVA Short Interest INVA Short Interest CNTA Short Interest OPK Short Interest ETNB Short Interest IRWD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCYC) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings